HRP20040109A2 - Screening method for inhibitors of folate synthesis pathway enzimes - Google Patents
Screening method for inhibitors of folate synthesis pathway enzimes Download PDFInfo
- Publication number
- HRP20040109A2 HRP20040109A2 HR20040109A HRP20040109A HRP20040109A2 HR P20040109 A2 HRP20040109 A2 HR P20040109A2 HR 20040109 A HR20040109 A HR 20040109A HR P20040109 A HRP20040109 A HR P20040109A HR P20040109 A2 HRP20040109 A2 HR P20040109A2
- Authority
- HR
- Croatia
- Prior art keywords
- dhps
- activity
- determining
- inhibitory activity
- accordance
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 39
- 230000015572 biosynthetic process Effects 0.000 title claims description 14
- 235000019152 folic acid Nutrition 0.000 title claims description 12
- 238000003786 synthesis reaction Methods 0.000 title claims description 12
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 title claims description 11
- 239000011724 folic acid Substances 0.000 title claims description 10
- 229940014144 folate Drugs 0.000 title claims description 9
- 238000012216 screening Methods 0.000 title claims description 9
- 230000037361 pathway Effects 0.000 title claims description 6
- 239000003112 inhibitor Substances 0.000 title description 31
- 108010065780 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase Proteins 0.000 claims description 72
- 230000000694 effects Effects 0.000 claims description 56
- 102100031242 Deoxyhypusine synthase Human genes 0.000 claims description 53
- 101000844963 Homo sapiens Deoxyhypusine synthase Proteins 0.000 claims description 53
- 238000012360 testing method Methods 0.000 claims description 46
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims description 40
- 102000004190 Enzymes Human genes 0.000 claims description 35
- 108090000790 Enzymes Proteins 0.000 claims description 35
- 238000006243 chemical reaction Methods 0.000 claims description 34
- VOJUXHHACRXLTD-UHFFFAOYSA-M 1,4-dihydroxy-2-naphthoate Chemical compound C1=CC=C2C(O)=CC(C([O-])=O)=C(O)C2=C1 VOJUXHHACRXLTD-UHFFFAOYSA-M 0.000 claims description 31
- 108010089355 dihydroneopterin aldolase Proteins 0.000 claims description 31
- 150000001875 compounds Chemical class 0.000 claims description 28
- 239000000758 substrate Substances 0.000 claims description 25
- 230000002401 inhibitory effect Effects 0.000 claims description 20
- 239000012429 reaction media Substances 0.000 claims description 19
- 238000001514 detection method Methods 0.000 claims description 18
- 229910052816 inorganic phosphate Inorganic materials 0.000 claims description 17
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 15
- YQIFAMYNGGOTFB-XINAWCOVSA-N 7,8-dihydroneopterin Chemical compound N1CC([C@H](O)[C@H](O)CO)=NC2=C1N=C(N)NC2=O YQIFAMYNGGOTFB-XINAWCOVSA-N 0.000 claims description 14
- 229910019142 PO4 Inorganic materials 0.000 claims description 14
- 239000010452 phosphate Substances 0.000 claims description 14
- 102000009609 Pyrophosphatases Human genes 0.000 claims description 13
- 108010009413 Pyrophosphatases Proteins 0.000 claims description 13
- 230000002255 enzymatic effect Effects 0.000 claims description 13
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 13
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 claims description 12
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical group [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims description 9
- 235000011180 diphosphates Nutrition 0.000 claims description 9
- 238000011534 incubation Methods 0.000 claims description 8
- CQQNNQTXUGLUEV-UHFFFAOYSA-N 2-amino-6-(hydroxymethyl)-7,8-dihydropteridin-4-ol Chemical compound N1CC(CO)=NC2=C1N=C(N)NC2=O CQQNNQTXUGLUEV-UHFFFAOYSA-N 0.000 claims description 6
- 238000000338 in vitro Methods 0.000 claims description 5
- 238000012544 monitoring process Methods 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 230000002285 radioactive effect Effects 0.000 claims description 5
- DPTKHUJHZQQZJX-UHFFFAOYSA-N 2-amino-6-(hydroxymethyl)-7,8-dihydro-1h-pteridin-4-one;phosphono dihydrogen phosphate Chemical compound OP(O)(=O)OP(O)(O)=O.N1=C(CO)CNC2=NC(N)=NC(O)=C21 DPTKHUJHZQQZJX-UHFFFAOYSA-N 0.000 claims description 4
- 239000012634 fragment Substances 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 3
- 238000004737 colorimetric analysis Methods 0.000 claims description 3
- 229920001184 polypeptide Polymers 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 238000005558 fluorometry Methods 0.000 claims description 2
- 238000005259 measurement Methods 0.000 claims description 2
- 101150052370 fol1 gene Proteins 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 description 15
- 235000018102 proteins Nutrition 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- WBFYVDCHGVNRBH-UHFFFAOYSA-N 7,8-dihydropteroic acid Chemical compound N=1C=2C(=O)NC(N)=NC=2NCC=1CNC1=CC=C(C(O)=O)C=C1 WBFYVDCHGVNRBH-UHFFFAOYSA-N 0.000 description 5
- 241000222122 Candida albicans Species 0.000 description 5
- 239000007983 Tris buffer Substances 0.000 description 5
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 5
- 229960004050 aminobenzoic acid Drugs 0.000 description 4
- 238000006911 enzymatic reaction Methods 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 4
- 108700016256 Dihydropteroate synthases Proteins 0.000 description 3
- 102000009617 Inorganic Pyrophosphatase Human genes 0.000 description 3
- 108010009595 Inorganic Pyrophosphatase Proteins 0.000 description 3
- 102000006833 Multifunctional Enzymes Human genes 0.000 description 3
- 108010047290 Multifunctional Enzymes Proteins 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 101150084750 1 gene Proteins 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000233872 Pneumocystis carinii Species 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000001851 biosynthetic effect Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 150000002224 folic acids Chemical class 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000004816 paper chromatography Methods 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- MSTNYGQPCMXVAQ-RYUDHWBXSA-N (6S)-5,6,7,8-tetrahydrofolic acid Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2N1)N)NC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-RYUDHWBXSA-N 0.000 description 1
- MWZMHLBLVDPOJE-UHFFFAOYSA-N 1-[4-[[n'-(4,6-dimethylpyrimidin-2-yl)carbamimidoyl]amino]phenyl]sulfonyl-3-phenylurea Chemical compound CC1=CC(C)=NC(N=C(N)NC=2C=CC(=CC=2)S(=O)(=O)NC(=O)NC=2C=CC=CC=2)=N1 MWZMHLBLVDPOJE-UHFFFAOYSA-N 0.000 description 1
- FSSVRLXFJPQUTM-WCCKRBBISA-N 2-aminoacetic acid;(2s)-2-amino-4-methylsulfanylbutanoic acid Chemical compound NCC(O)=O.CSCC[C@H](N)C(O)=O FSSVRLXFJPQUTM-WCCKRBBISA-N 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 1
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- 101710167959 Putative UTP-glucose-1-phosphate uridylyltransferase Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 108010022394 Threonine synthase Proteins 0.000 description 1
- 108700023183 UTP-glucose-1-phosphate uridylyltransferases Proteins 0.000 description 1
- 102000048175 UTP-glucose-1-phosphate uridylyltransferases Human genes 0.000 description 1
- 101100339555 Zymoseptoria tritici HPPD gene Proteins 0.000 description 1
- GBXZONVFWYCRPT-JGWLITMVSA-N [(2r,3s,4r,5r)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl] dihydrogen phosphate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)OP(O)(O)=O GBXZONVFWYCRPT-JGWLITMVSA-N 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- QGAVSDVURUSLQK-UHFFFAOYSA-N ammonium heptamolybdate Chemical compound N.N.N.N.N.N.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Mo].[Mo].[Mo].[Mo].[Mo].[Mo].[Mo] QGAVSDVURUSLQK-UHFFFAOYSA-N 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000842 anti-protozoal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003904 antiprotozoal agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- GYOZYWVXFNDGLU-XLPZGREQSA-N dTMP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 GYOZYWVXFNDGLU-XLPZGREQSA-N 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 102000004419 dihydrofolate reductase Human genes 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- FRGKKTITADJNOE-UHFFFAOYSA-N sulfanyloxyethane Chemical compound CCOS FRGKKTITADJNOE-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 238000012956 testing procedure Methods 0.000 description 1
- 239000005460 tetrahydrofolate Substances 0.000 description 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 1
- 229960001082 trimethoprim Drugs 0.000 description 1
- 101150034486 trpG gene Proteins 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01402085A EP1281769A1 (de) | 2001-08-01 | 2001-08-01 | Screening-Verfahren für Inhibitoren von Enzymen der Folat Synthese |
PCT/EP2002/009421 WO2003012132A2 (en) | 2001-08-01 | 2002-07-30 | Screening method for inhibitors of folate synthesis pathway enzymes |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20040109A2 true HRP20040109A2 (en) | 2004-06-30 |
Family
ID=8182836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20040109A HRP20040109A2 (en) | 2001-08-01 | 2004-01-30 | Screening method for inhibitors of folate synthesis pathway enzimes |
Country Status (6)
Country | Link |
---|---|
US (1) | US20060088900A1 (de) |
EP (2) | EP1281769A1 (de) |
JP (1) | JP2005508620A (de) |
AU (1) | AU2002327846A1 (de) |
HR (1) | HRP20040109A2 (de) |
WO (1) | WO2003012132A2 (de) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH670709A5 (de) * | 1986-04-24 | 1989-06-30 | Univ Moskovsk | |
EP0999284A1 (de) * | 1998-09-11 | 2000-05-10 | Hoechst Marion Roussel | Verfahren zum Screening auf Antimykotika unter Verwendung essentieller Gene aus C.albicans, sowie die Gene selbst |
CA2355816C (en) * | 1998-12-14 | 2007-10-30 | Li-Cor, Inc. | A system and methods for nucleic acid sequencing of single molecules by polymerase synthesis |
AU1994800A (en) * | 1999-01-15 | 2000-08-01 | Pantherix Ltd. | Phosphate release enzyme assay |
US7202023B2 (en) * | 2000-08-11 | 2007-04-10 | Millennium Pharmaceuticals, Inc. | High throughput screen for inhibitors of the folate biosynthetic pathway in bacteria |
-
2001
- 2001-08-01 EP EP01402085A patent/EP1281769A1/de not_active Withdrawn
-
2002
- 2002-07-30 AU AU2002327846A patent/AU2002327846A1/en not_active Abandoned
- 2002-07-30 WO PCT/EP2002/009421 patent/WO2003012132A2/en not_active Application Discontinuation
- 2002-07-30 JP JP2003517306A patent/JP2005508620A/ja active Pending
- 2002-07-30 EP EP02762460A patent/EP1414993A2/de not_active Withdrawn
- 2002-07-30 US US10/485,346 patent/US20060088900A1/en not_active Abandoned
-
2004
- 2004-01-30 HR HR20040109A patent/HRP20040109A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2005508620A (ja) | 2005-04-07 |
EP1281769A1 (de) | 2003-02-05 |
AU2002327846A1 (en) | 2003-02-17 |
EP1414993A2 (de) | 2004-05-06 |
WO2003012132A3 (en) | 2003-08-28 |
US20060088900A1 (en) | 2006-04-27 |
WO2003012132A2 (en) | 2003-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Patricelli et al. | In situ kinase profiling reveals functionally relevant properties of native kinases | |
Smith et al. | Identification of a redox-sensitive switch within the JAK2 catalytic domain | |
KR20010032048A (ko) | 게놈 접근법을 사용하여 동정된 단백질을 기능적으로분류하는 고처리량 방법 | |
US20120164670A1 (en) | Methods and kits for measuring enzyme activity | |
Park et al. | Protein ubiquitination and formation of polyubiquitin chains without ATP, E1 and E2 enzymes | |
Phelan et al. | Adenylation enzyme characterization using γ-18O4-ATP pyrophosphate exchange | |
Eriksson et al. | Method for real-time detection of inorganic pyrophosphatase activity | |
Fisher et al. | A sensitive, high-volume, colorimetric assay for protein phosphatases | |
US20080050762A1 (en) | Methods and compositions for coupled luminescent assays | |
Camara et al. | Inhibition of p-aminobenzoate and folate syntheses in plants and apicomplexan parasites by natural product rubreserine | |
Branstrom et al. | Assay for identification of inhibitors for bacterial MraY translocase or MurG transferase | |
Kröplin et al. | Inhibition of thiopurine S-methyltransferase activity by impurities in commercially available substrates: a factor for differing results of TPMT measurements | |
Loring et al. | Yeast Chfr homologs retard cell cycle at G1 and G2/M via Ubc4 and Ubc13/Mms2-dependent ubiquitination | |
Chakraborty et al. | Profiling of the drug resistance of thousands of Src tyrosine kinase mutants uncovers a regulatory network that couples autoinhibition to catalytic domain dynamics | |
US20130122514A1 (en) | Methods for determination of protein phosphatase activity, and uses in predicting therapeutic outcomes | |
Saini et al. | High-throughput microplate phosphorylation assays based on DevR-DevS/Rv2027c 2-component signal transduction pathway to screen for novel antitubercular compounds | |
HRP20040109A2 (en) | Screening method for inhibitors of folate synthesis pathway enzimes | |
Valderas et al. | Examination of intrinsic sulfonamide resistance in Bacillus anthracis: a novel assay for dihydropteroate synthase | |
Šebela | The use of matrix‐assisted laser desorption/ionization mass spectrometry in enzyme activity assays and its position in the context of other available methods | |
LECLERC et al. | Serine/threonine phosphorylation of calmodulin modulates its interaction with the binding domains of target enzymes | |
US20050004068A1 (en) | Modulation of tor | |
Brault et al. | Characterization of cytidylyltransferase enzyme activity through high performance liquid chromatography | |
Bruni et al. | An endpoint enzymatic assay for fructose 2, 6-bisphosphate performed in 96-well plates | |
DE60103061T2 (de) | Verfahren zur identifizierung von verbindungen, die den anaphase-fördernden komplex hemmen | |
Fernley et al. | A rapid assay for dihydropteroate synthase activity suitable for identification of inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
OBST | Application withdrawn |